pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,968 catalysts · 3,603 8k filing · 2,670 grant · 2,420 approval · 1,702 device 510k · 1,263 device recall · 1,164 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-09-30×clear all
type
  • 8k filing3,603
  • grant2,670
  • approval2,420
  • device 510k1,702
  • device recall1,263
  • device pma1,164
  • device adverse event1,000
  • earnings585
  • recall481
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 29, 2025

    50
    ›Sep 30, 2025grant333d agoBOSTON CHILDREN'S HOSPITAL — VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)Boston Children's Hospital

    AI grant. $1,112,104. PI: OFER LEVY

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF MONTANA — Identification of Novel Syk/Raf-1 Mediated CLR Ligands as Vaccine Adjuvants

    AI grant. $1,561,142. PI: JAY EVANS

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoESPER BIOSCIENCES, INC. — Rapid Point-of-Care Nucleic Acid Test for Hepatitis C using Nanosensors

    PS grant. $423,833. PI: Jonathan Alden

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF MONTANA — Chromatin state contributions to cytoplasmic incompatibility

    GM grant. $78,040. PI: Hunter James Hill

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Sensorimotor processing in the oculomotor system: moving targets and intercep...

    EY grant. $1,038,798. PI: Neeraj J Gandhi

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoPUBLIC HEALTH FOUNDATION ENTERPRISES — Behavioral Safety and Fentanyl Education: BSAFENutriBand Inc.

    DA grant. $620,164. PI: Alexander Reza Bazazi

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoNEOVASCULARX, INC — Topical Ophthalmic Treatment for Neovascular Age-related Macular Degeneration...NeoVascularX Inc

    EY grant. $305,321. PI: Hiroaki Serizawa

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Effects of Medicare’s wage index on patient access and hospital care quality ...

    AG grant. $671,273. PI: GEOFFREY JONATHAN HOFFMAN

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoNEW YORK UNIVERSITY — Processing of visual information by spatial memory circuits in the avian brainNew York University

    EY grant. $224,100. PI: Hannah L Payne

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoNATIONAL OPINION RESEARCH CENTER — CE25-027 - Evaluate STEADI-based Fall Prevention in Assisted Living Facilities

    CE grant. $699,824. PI: David B Rein

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoCHROMOLOGIC, LLC — Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission

    OH grant. $306,469. PI: Dmitriy V Zhukov

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoNATIONAL OPINION RESEARCH CENTER — CE25-025 - Preventing ACES with Linkages and Stronger Systems (PALSS)

    CE grant. $449,928. PI: Margaret Hargreaves

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoRESEARCH TRIANGLE INSTITUTE — Rigorous Evaluation of Training in Alcohol-Serving Venues for Sexual Violence...

    CE grant. $499,959. PI: Marni L Kan

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoHAWAI'I INNOVATION INC. — METAVEST: Advanced Biomimetic Personal Cooling for Enhancing Heat Safety Amon...

    OH grant. $302,424. PI: Arif Rahman

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF CALIFORNIA BERKELEY — Evaluation of State-Level Sexual and Gender Minority Laws for the Primary Pre...

    CE grant. $500,000. PI: Sabrina Christine Boyce

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoLO BIOSCIENCES, INC. — A novel remote blood separation device for at-home plasma collection for HIV-...

    PS grant. $994,658. PI: Maria de los Angeles JAIME

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoMASSACHUSETTS GENERAL HOSPITAL — High-Dose Medications for Opioid Use Disorder: Effects on Treatment Retention...Massachusetts General Hospital

    CE grant. $348,837. PI: Huiru Dong

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — CE25-021 - Development and Rigorous Evaluation of Culturally Grounded Crime P...

    CE grant. $400,000. PI: Katie M Edwards

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarke...University of Utah

    AG grant. $5,789,766. PI: Adam P Bress

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoSTANFORD UNIVERSITY — Effects of Health Shocks at Older Age on Older Adults and their Families: New...Stanford University

    AG grant. $620,020. PI: Maria Polyakova

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Lifestyle Change Implementation Research Network at PRC at UMass Chan

    DP grant. $499,993. PI: Jamie Faro

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoGEORGE MASON UNIVERSITY — Preventing intimate partner violence among refugee populations in the United ...

    CE grant. $374,759. PI: Jhumka Gupta

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoSTANFORD UNIVERSITY — Peripheral nervous system agingStanford University

    AG grant. $1,123,001. PI: ANNE BRUNET

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF MINNESOTA — Defining the role of Fzd6 in lymphatic network development and functionUniversity of Minnesota

    HL grant. $35,375. PI: Evalyn Beall

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoUNIVERSITY OF NOTRE DAME — Combining ecological momentary assessment and qualitative methods to construc...

    AA grant. $49,538. PI: Melissa Nance

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoOHIO STATE UNIVERSITY — Mechanisms of neuronal TRPM2 channel effects on Post-Stroke Cognitive Impairment

    NS grant. $44,916. PI: Kelley A. Coakley

    full page →nih reporter ↗
    ›Sep 30, 2025grant333d agoSTANFORD UNIVERSITY — Unveil the functional role of RNA spatial localization in neuronal function a...Stanford University

    NS grant. $49,538. PI: Maylin Fu

    full page →nih reporter ↗
    ›Oct 1, 2025approval332d agoVONJO (PACRITINIB CITRATE) — FDA approvalpacritinib

    Sponsor: SOBI. Form: CAPSULE. Route: ORAL

    full page →pacritinib →fda approvals ↗
    ›Oct 1, 2025approval332d agoMORPHINE SULFATE — FDA approvalKapanol

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →Kapanol →fda approvals ↗
    ›Oct 1, 2025approval332d agoHYDROMORPHONE HYDROCHLORIDE — FDA approvalSpecGx LLC

    Sponsor: PADAGIS US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: GRANULES. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Oct 1, 2025approval332d agoSIMPONI (GOLIMUMAB) — FDA approvalJanssen Biotech Inc

    Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Oct 1, 2025approval332d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Oct 1, 2025approval332d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: GLENMARK PHARMS LTD. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Oct 1, 2025approval332d agoFLUOCINOLONE ACETONIDE — FDA approvalEclipse Life Sciences Inc

    Sponsor: PADAGIS ISRAEL. Form: OIL. Route: TOPICAL

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoFLUOCINOLONE ACETONIDE — FDA approvalEclipse Life Sciences Inc

    Sponsor: PADAGIS ISRAEL. Form: OIL/DROPS. Route: OTIC

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoDORZOLAMIDE HYDROCHLORIDE — FDA approvalDORZOLAMIDE HYDROCHLORIDE

    Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →DORZOLAMIDE HYDROCHLORIDE →fda approvals ↗
    ›Oct 1, 2025approval332d agoDORZOLAMIDE HYDROCHLORIDE — FDA approvalDORZOLAMIDE HYDROCHLORIDE

    Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →DORZOLAMIDE HYDROCHLORIDE →fda approvals ↗
    ›Oct 1, 2025approval332d agoDIAMOX (ACETAZOLAMIDE) — FDA approvalAccord Healthcare Inc

    Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoPREDNISONE — FDA approvalVintage Pharmaceuticals Inc (Inactive)

    Sponsor: DR REDDYS. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 1, 2025approval332d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: ANNORA PHARMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 1, 2025approval332d agoLETROZOLE — FDA approvalLETROZOLE

    Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

    full page →LETROZOLE →fda approvals ↗
    ›Oct 1, 2025approval332d agoLETROZOLE — FDA approvalLETROZOLE

    Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL

    full page →LETROZOLE →fda approvals ↗
    ›Oct 1, 2025approval332d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: ACS DOBFAR SPA. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Oct 1, 2025approval332d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: ACS DOBFAR SPA. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Oct 1, 2025approval332d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

    full page →PANTOPRAZOLE SODIUM →fda approvals ↗
    ›Oct 1, 2025approval332d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

    full page →PANTOPRAZOLE SODIUM →fda approvals ↗
    ›Oct 1, 2025approval332d agoPANTOPRAZOLE SODIUM — FDA approvalPANTOPRAZOLE SODIUM

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

    full page →PANTOPRAZOLE SODIUM →fda approvals ↗
    ›Oct 1, 2025approval332d agoANTARA (MICRONIZED) (FENOFIBRATE) — FDA approvalFENOFIBRATE

    Sponsor: LUPIN. Form: CAPSULE. Route: ORAL

    full page →FENOFIBRATE →fda approvals ↗
    ← prev
    page 7 of 300
    next →
    $NTRB2.9000-11.59%